126 results
Page 3 of 7
8-K
EX-99.1
o7z7iw84zzg5 blwmo00
4 Nov 21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
EX-99.1
g1pyqnpiemm178qfy
5 Aug 21
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results
4:14pm
8-K
EX-99.1
iucui9tqwij9sjskr
28 Jun 21
Other Events
6:07am
8-K
xkca0c 1wdagulp
28 Jun 21
Other Events
6:07am
8-K
u8cz30 2b
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
p91hz7p0
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.2
n2rwp4wltn6 bzsuy9dw
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
9aiw73ty7th a0i8
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
03oa3
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
EX-99.1
6o1suaya
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
EX-99.1
22pabeg0r 4aoobv
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
2si44xdn7qa9ck
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
EX-99.1
zbu8 aef4055vy
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm
8-K
bz6l07rb9p6kcs
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm